Private Equity

A $300M tugboat deal pushes Woodside's investment in Louisiana past $1 billion, boosting the state's maritime industry and its role in global energy.

Interim trial data shows IPH5201 plus durvalumab yields pathological complete response rates up to 50%, far surpassing current standards for resectable NSCLC.

With 60,000+ attendees and 650+ events, SF Climate Week 2026 questions if massive, decentralized gatherings can truly accelerate climate solutions.

Nested Therapeutics' NST-628 reports a 38% response rate in advanced melanoma, offering new hope with a novel, brain-penetrating cancer-fighting agent.

Interim study results suggest a common food product may significantly enhance the effectiveness of modern cancer treatments, heralding a new era of care.

A surprise $5 million pledge for glaucoma research highlights a gala honoring philanthropist Daria Barry, patient advocate Hillary Golden, and music icon Nile Rodgers.

Backed by a $1M pledge for America's first Paralympic Blind Soccer team, an ambassador challenges FIFA to include disabled athletes on the world's biggest stage.

Singapore's aquatic education leader prices a complex public offering to fuel a pivot into new sports, facing investor scrutiny and a volatile stock history.

Vaxart's new $25M financing deal provides a crucial cash runway, but is it a savvy strategic move or a necessary step to stay in the race?

As the Boston Marathon marks its 130th run, Boston Globe Media celebrates a parallel legacy with its most ambitious, multi-platform coverage strategy yet.

Brunswick's Freedom Boat Club just bought its largest franchise, signaling a strategic consolidation and a major bet on the 'boating-as-a-service' model.

The 'Big Red Rebuild' aims to transform Memorial Stadium, promising a $1.1B economic boost without taxpayer funds. But can it balance legacy and profit?

A new global olive leader, Arvos, unites producers from four nations, aiming to simplify retail and dominate the growing chilled Mediterranean food market.

With global regulatory approvals secured, Gilead extends its tender offer for Arcellx, moving closer to acquiring a potential best-in-class CAR T therapy.

A new report reveals the Nordic life science sector isn't lacking female talent; it's failing to convert it into leadership, threatening innovation.

Industrial Thermal Services' acquisition of NDE Inc. signals a major shift toward integrated solutions, backed by private equity's strategic vision.

Preliminary Q1 data from Auna shows rising demand for specialized care in Peru, Colombia, and Mexico, offering investors a transparent new look.

A new campaign from L'Oréal Paris and Ulta Beauty challenges one-dimensional views of motherhood, blending social commentary with a powerful retail strategy.

A new zero-deforestation deal aims to make Mexican avocados sustainable. But with a history of weak enforcement, can it truly protect the country's forests?

As HASI sets its Q1 2026 earnings date, investors watch for clues on its growth and the health of the broader sustainable infrastructure market.